AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2018
May 24, 2018
35146_dirs_2018-05-24_8eef0955-29a0-4e4e-87b4-9d05d6afaf71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-05-23
Reporting Person: Rafaeli Dolev (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-23 | STRATA Stock Options (right to buy) | $1.66 | A | 1413249 | Acquired | 2028-05-23 | Common Stock (1413249) | Direct |
Footnotes
F1: The Options shall be exercisable in twelve equal quarterly installments commencing on August 23, 2018 and continuing through May 23, 2020.
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16